News Story: Full Text
Sponsored By
NovoCure Trial
Please Click On The Above Banner For More Details
Braintumor Website

 

Good Progress in Phase 1 Study of MediGene`s Novel Anticancer Therapeutic NV1020 to Treat Colorectal Cancer Metastatic to the Liver (PR Newswire)...This combination of properties makes NV1020 ideally suited as a unique anti-tumor therapeutic.......MediGene recently announced that its other modified HSV-1 anticancer candidate, G207, for treatment of brain tumors, has successfully completed phase 1 clinical trials and is about to enter further clinical development....- Mar 21 8:31 AM ET


IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/prnews/010321/lnw010.html


(Everything below this line is from VirtualTrials.com!)

Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740